Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (991-1000 of 1,157) with videos related to

Pageof 116
Sort By:
The Journal of Headache and Pain|March 23, 2023
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 studyPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 LockdownMilena Zucca, Valeria Isella, Raffaele Di Lorenzo, et al.
Neurorehabilitation and Neural Repair|April 25, 2026
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx StudyCecilia Meza, Roberto S Hernandez, Silvana L Costa, et al.
Neurology|January 23, 2023
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum DisorderLaura Cacciaguerra, Pearse Morris, W Oliver Tobin, et al.
Brain Communications|April 25, 2024
Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variantsFrancesca Orlandi, Arenn F Carlos, Farwa Ali, et al.
Journal of Neurology|September 23, 2025
Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trialFrancesco Romanò, Maria A Rocca, Elisabetta Pagani, et al.
Nature Reviews. Neurology|February 26, 2020
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practiceJaume Sastre-Garriga, Deborah Pareto, Marco Battaglini, et al.
Parkinsonism & Related Disorders|January 22, 2023
Longitudinal clinical decline and baseline predictors in progressive supranuclear palsyCostanza Pavone, Stephen W Weigand, Farwa Ali, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 2, 2021
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS RegisterEmanuele D'Amico, Aurora Zanghì, Marzia Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
Pageof 116

Showing results (991-1000 of 1,157) with videos related to

Sort By:
Pageof 116
The Journal of Headache and Pain|March 23, 2023
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 studyPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 LockdownMilena Zucca, Valeria Isella, Raffaele Di Lorenzo, et al.
Neurorehabilitation and Neural Repair|April 25, 2026
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx StudyCecilia Meza, Roberto S Hernandez, Silvana L Costa, et al.
Neurology|January 23, 2023
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum DisorderLaura Cacciaguerra, Pearse Morris, W Oliver Tobin, et al.
Brain Communications|April 25, 2024
Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variantsFrancesca Orlandi, Arenn F Carlos, Farwa Ali, et al.
Journal of Neurology|September 23, 2025
Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trialFrancesco Romanò, Maria A Rocca, Elisabetta Pagani, et al.
Nature Reviews. Neurology|February 26, 2020
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practiceJaume Sastre-Garriga, Deborah Pareto, Marco Battaglini, et al.
Parkinsonism & Related Disorders|January 22, 2023
Longitudinal clinical decline and baseline predictors in progressive supranuclear palsyCostanza Pavone, Stephen W Weigand, Farwa Ali, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 2, 2021
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS RegisterEmanuele D'Amico, Aurora Zanghì, Marzia Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
Pageof 116